Between fact and technique: The beginnings of hybridoma technology

@article{Cambrosio1992BetweenFA,
  title={Between fact and technique: The beginnings of hybridoma technology},
  author={Alberto Cambrosio and Peter Keating},
  journal={Journal of the History of Biology},
  year={1992},
  volume={25},
  pages={175-230}
}
ConclusionAt several places in this paper we have made use of a well-known rhetorical device: an argument was made; a character —dubbed “fictional reader” — was then evoked who voiced some objections against that particular argument; and finally, we answered those objections, thus bringing to a close, at least temporarily, our argument. The use of this device raises a question: “How is the presence of the ‘fictional reader” to be understood?” Is it a “mere” rhetorical tool, or does this… 

Color on the Biological and Biochemical Front

One of the many things that the German dye companies excelled at was seeing the long-range and global picture and acting upon it. They went very large-scale on virtually every front, utilizing all

Constituting Novel Entities in Immunology

TLDR
An ethnographic account of the proliferation of immunological entities known as T lymphocyte (or T cell) subsets, which have been recently implicated in the definition and diagnosis of diseases such as AIDS, leukemia, and autoimmune diseases, as well as in the monitoring of transplant patients are offered.

Immunostaining of Voltage-Gated Ion Channels in Cell Lines and Neurons – Key Concepts and Potential Pitfalls

Widely acknowledged to be the first person to make detailed studies of microscopic objects, the pioneering work of Antonie van Leeuwenhoek (1632-1723) provided the first glimpse of neurons when he

1 Immunostaining of Voltage-Gated Ion Channels in Cell Lines and Neurons – Key Concepts and Potential Pitfalls

Widely acknowledged to be the first person to make detailed studies of microscopic objects, the pioneering work of Antonie van Leeuwenhoek (1632-1723) provided the first glimpse of neurons when he

Deciphering the therapeutic stem cell strategies of large and midsize pharmaceutical firms.

TLDR
In times of decreased industry average research productivities, regenerative medicine products provide important prospects for creating new franchises with a market potential that could very well mirror that achieved with the technology of monoclonal antibodies.

The interference of monoclonal antibodies with laboratory diagnosis: clinical and diagnostic implications

TLDR
Recognition of the types of interference, endogenous and exogenous, and the varied mechanisms by which monoclonal antibodies may cause interference are discussed in this report.

PHARMACEUTICAL MONOCLONAL ANTIBODIES: PRODUCTION, GUIDELINES TO CELL ENGINEERING AND APPLICATIONS

TLDR
Production, regulatory guidelines to cell engineering and applications of monoclonal antibodies are discussed, which hold great interest to improve cell growth and productivity, as well as product quality in the future.